Rani Therapeutics (RANI) Revenue & Revenue Breakdown
Rani Therapeutics Revenue Highlights
00
Rani Therapeutics Revenue by Period
Rani Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | -100.00% |
2021-12-31 | $2.72M | 488.10% |
2020-12-31 | $462.00K | -52.81% |
2019-12-31 | $979.00K | - |
Rani Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $2.75M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $-2.72M | 100.00% |
2021-09-30 | - | -100.00% |
2021-06-30 | $1.96M | 159.39% |
2021-03-31 | $756.00K | 260.00% |
2020-12-31 | $210.00K | 94.44% |
2020-09-30 | $108.00K | 80.00% |
2020-06-30 | $60.00K | -27.71% |
2020-03-31 | $83.00K | - |
Rani Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EYPT | EyePoint Pharmaceuticals | $46.02M | $10.52M |
MOLN | Molecular Partners | $7.04M | $2.74M |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
VCNX | Vaccinex | $570.00K | $52.00K |
CRVS | Corvus Pharmaceuticals | - | - |
ALXO | ALX Oncology | - | - |
CABA | Cabaletta Bio | - | - |
PHVS | Pharvaris | - | - |
TARA | Protara Therapeutics | - | - |
VIRX | Viracta Therapeutics | - | - |
BMEA | Biomea Fusion | - | - |
TRVI | Trevi Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MNPR | Monopar Therapeutics | - | - |
VINC | Vincerx Pharma | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
SRZN | Surrozen | - | - |
TNYA | Tenaya Therapeutics | - | - |
RANI | Rani Therapeutics | - | - |
TYRA | Tyra Biosciences | - | - |